2-ETHOXY-4-FORMYLPHENYL 2,4-DICHLOROBENZOATE
|
- $95 - $455
- Product name: 2-ETHOXY-4-FORMYLPHENYL 2,4-DICHLOROBENZOATE
- CAS: 444110-64-9
- MF: C16H12Cl2O4
- MW: 339.17
- EINECS:
- MDL Number:MFCD03422508
- Synonyms:2-ETHOXY-4-FORMYLPHENYL 2,4-DICHLOROBENZOATE;(2-ethoxy-4-methanoyl-phenyl) 2,4-dichlorobenzoate;2,4-dichlorobenzoic acid (2-ethoxy-4-formylphenyl) ester;2,4-dichlorobenzoic acid (2-ethoxy-4-formyl-phenyl) ester;Oprea1_819035;SBB005078;ZINC00309228;2-Ethoxy-4-formylpenyl 2,4-dichlorobenzoate
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 0.5G
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0039885
- Product description2-ETHOXY-4-FORMYLPHENYL 2,4-DICHLOROBENZOATE 95.00%
- Packaging0.5G
- Price$252
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12071352
- Product description2-Ethoxy-4-formylphenyl2,4-dichlorobenzoate 97%
- Packaging5g
- Price$455
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number028733
- Product description2-Ethoxy-4-formylphenyl 2,4-dichlorobenzoate
- Packaging500mg
- Price$95
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0039885 | 2-ETHOXY-4-FORMYLPHENYL 2,4-DICHLOROBENZOATE 95.00% | 0.5G | $252 | 2021-12-16 | Buy |
| Crysdot | CD12071352 | 2-Ethoxy-4-formylphenyl2,4-dichlorobenzoate 97% | 5g | $455 | 2021-12-16 | Buy |
| Matrix Scientific | 028733 | 2-Ethoxy-4-formylphenyl 2,4-dichlorobenzoate | 500mg | $95 | 2021-12-16 | Buy |
Properties
Melting point :117-118 °C(Solv: benzene (71-43-2); hexane (110-54-3))
Boiling point :520.4±50.0 °C(Predicted)
Density :1.362±0.06 g/cm3(Predicted)
Boiling point :520.4±50.0 °C(Predicted)
Density :1.362±0.06 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|